AUGS members are represented by a 13-member Board of Directors who is responsible for setting the overall strategic direction of the society. The Board is comprised of five officers and eight Directors-at-Large. The officers of the Society include a President, President-Elect, Vice President, Immediate Past President and a Treasurer.
Terms expire at the conclusion of the annual scientific meeting for the year indicated.
AUGS members can send communications to the Board of Directors using the board@augs.org email address.
Officers
President
Shawn A. Menefee, MD
Kaiser Permanente, San Diego
San Diego, CA
Term Expires: 2020
Corporate Disclosures: Author Royalties - UptoDate
President Elect
Holly Richter, PhD, MD
University of Alabama at Birmingham
Birmingham, AL
Term Expires: 2020
Corporate Disclosures: Research Grant - Pelvalon; Consultant/Advisory Board - Pelvalon, Renovia, BlueWind Medical; Author Royalties - BlueWind Medical, UptoDate
Vice President
Elizabeth R. Mueller, MD
Loyola University Stritch School of Medicine
Maywood, IL
Term Expires: 2020
Treasurer
Michael K. Flynn, MD, MS
University of Massachusetts
Worcester, MA
Term Expires: 2021
Corporate Disclosures: None
Immediate Past President
Geoffrey W. Cundiff, MD, FACOG, FACS, FRCSC
University of British Columbia
Vancouver, BC Canada
Term Expires: 2020
Corporate Disclosures: None
Directors-at-Large
Tanaz R. Ferzandi, MD, MBA
Keck School of Medicine at USC
Boston, MA
Term Expires: 2021
Corporate Disclosures: Consultant/Advisory Board - Hologic, Inc.
Margaret Mueller, MD
Northwestern University Feinberg School of Medicine
Chicago, IL
Term Expires: 2022
Lieschen H. Quiroz, MD
Oklahoma University Health Sciences Center
Oklahoma City, OK
Term Expires: 2021
Corporate Disclosures: Research Grants - Pelvalon, Cook
David D. Rahn, MD
UT Southwestern
Dallas, TX
Term Expires: 2022
Eric R. Sokol, MD
Stanford University School of Medicine
Stanford, CA
Term Expires: 2020
Corporate Disclosures: Research Grants - ACell, Coloplast, Cook, Foundation for Female Health Awareness; Stock Holdings - Pelvalon
Elisa R. Trowbridge
University of Virginia
Charlottesville, VA
Term Expires: 2020
Corporate Disclosures: None
PFD Research Foundation Chair
Christopher M. Tarnay, MD
UCLA School of Medicine
Los Angeles, CA
Term Expires: 2021
Corporate Disclosures: None
PFD Research Foundation Vice Chair
Elizabeth Geller, MD
University of North Carolina
Chapel Hill, NC
Term Expires: 2021
Corporate Disclosures: None
Ex-Officio Members
AUGS Executive Director
Michelle Zinnert, CAE
American Urogynecologic Society
Silver Spring, MD
ACOG Representative
Charles C. Kilpatrick, MD
Baylor College of Medicine
Houston, TX
Term Expires: 2019
Corporate Disclosures: Author Royalties - UptoDate, McGraw Hill
ABOG Representative
Marlene Corton, MD, MS
UT Southwestern Medical Center
Dallas, TX
Term Expires: 2021
Lieschen H. Quiroz, MD
Oklahoma University Health Sciences Center
Oklahoma City, OK
Term Expires: 2021
Corporate Disclosures: Research Grants - Pelvalon, Cook